Becoming a Member

Membership shall be available to entities interested in furthering the objectives of the Network. Companies that wish to become member should be active in biopharmaceuticals manufacturing, R&D, and/or clinical development in the LMICs. In case of public ownership, they should have its main office in a LMIC. In case of private ownership, the majority of shares needs to be hold by an entity having its main office in a LMIC.

 

Membership Advantages

·       EBPMN is the voice of its members on all areas impacting the emerging biopharmaceutical industry in LMICs

·       Be part of a global network committed to advance the interests of LMIC manufacturers

·       Increase your understanding and competence in scientific and technical product development, regulatory and legal issues and market access in the field of biopharmaceuticals, in particular biosimilars

·       Benefit from joint expertise and access to information

·       Enhance your influence at regional and global level

·       Network with other LMIC manufacturers, exploring collaborative partnerships and technology transfer

·       Attend meetings, training workshops, webinars and other events at sharply reduced rates

 

Members:

 

            

 

Annual Conference:

EBPMN’s Annual General Meeting may be hosted by one of the members. The meeting will consist of a closed business meeting for members, an open meeting dedicated to scientific, technological and regulatory advancements, courses, also open for non-members and exhibitions for service and product providers.

Interested Parties, Stakeholders & Sponsors:

As a preferred and recognized partner in (technical) cooperation with WHO, the Utrecht Centre for Affordable Biotherapeutics (UCAB) fulfilled a brokerage role in the establishment of the EBPMN.

 

 

Person filling in the application form

Applicable annual membership fee according to category: